Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Heartseed, Inc. ( (JP:219A) ) has issued an announcement.
Heartseed Inc. reported significant financial improvement for the twelve months ending October 31, 2025, with net sales rising to 3,026 million yen from 873 million yen the previous year. The company achieved a net profit of 592 million yen compared to a loss in the prior year, indicating a strong recovery and positive outlook for stakeholders.
The most recent analyst rating on (JP:219A) stock is a Hold with a Yen1361.00 price target. To see the full list of analyst forecasts on Heartseed, Inc. stock, see the JP:219A Stock Forecast page.
More about Heartseed, Inc.
Heartseed Inc. is a company listed on the Tokyo Stock Exchange, operating in the healthcare industry. It focuses on developing innovative treatments and therapies, with a significant emphasis on cardiac regenerative medicine.
Average Trading Volume: 1,882,905
Technical Sentiment Signal: Sell
Current Market Cap: Yen50.73B
Find detailed analytics on 219A stock on TipRanks’ Stock Analysis page.